Skip to main content
SpringerLink
Log in

Osteosarcoma studies at St. Jude Children’s Research Hospital from 1968 through 1990

  • Chapter
Osteosarcoma in Adolescents and Young Adults: New Developments and Controversies

Part of the book series: Cancer Treatment and Research ((CTAR,volume 62))

Abstract

St. Jude Children’s Research Hospital opened its doors in 1962. By 1968, stage-related treatment protocols for osteosarcoma were established. This paper will be limited to our investigations of the relatively new agent ifosfamide, adjuvant chemotherapy protocols, and the treatment of metastatic disease revealed at diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Pratt CB, Horowitz, Meyer WH, et al. Phase II trial of ifosfamide in children with malignant solid tumors. Cancer Treat Rep 71:131–135, 1987.

    PubMed  CAS  Google Scholar 

  2. Pratt CB, Douglass EC, Etcubanas E, et al. Clinical studies of ifosfamide/mesna at St. Jude Children’s Research Hospital, 1983–1988. Semin Oncol 16(Suppl 3): 51–55, 1989.

    PubMed  CAS  Google Scholar 

  3. Goren MP, Wright RK, Pratt CB, et al. Potentiation of ifosfamide neurotoxicity, hematotoxicity and tubular nephrotoxicity by prior cisplatin therapy. Cancer Res 47:1457–1460, 1987.

    PubMed  CAS  Google Scholar 

  4. Pratt CB, Goren MP, Meyer WH, et al. Ifosfamide neurotoxicity is related to previous cisplatin treatment for pediatric solid tumors. J Clin Oncol 8:1399–1401, 1990.

    PubMed  CAS  Google Scholar 

  5. Pratt CB, Green AA, Horowitz ME, et al. Central nervous system toxicity following treatment of pediatric patients with ifosfamide/mesna. J Clin Oncol 4:1253–1261, 1986.

    PubMed  CAS  Google Scholar 

  6. Goren MP, Wright RK, Horowitz ME, Pratt CB. Cancer chemotherapy-induced tubular nephrotoxicity evaluated by immunochemical determination of urinary adenosine deaminase binding protein. Am J Clin Pathol 86:780–783, 1986.

    PubMed  CAS  Google Scholar 

  7. Goren MP, Wright RK, Horowitz ME, Pratt CB. Ifosfamide induces subclinical tubular nephrotoxicity despite 2-mercaptoethane sulfonate sodium (mesna). Cancer Treat Rep 71:127–130, 1987.

    PubMed  CAS  Google Scholar 

  8. Goren MP, Pratt CB, Meyer WH, et al. Mesna excretion and ifosfamide nephrotoxicity in children. Cancer Res 49:7153–7157, 1989.

    PubMed  CAS  Google Scholar 

  9. Goren MP, Wright RK, Pratt CB, Pell FE. Dechloroethylation of ifosfamide and neurotoxicity (letter). Lancet 2:1219–1220, 1986.

    Article  PubMed  CAS  Google Scholar 

  10. Pratt CB, Bowman L, Douglass EC, et al. Ifosfamide/mesna (IFOS/M): alternative phase I schedules and dosages for pediatric malignant solid tumors (MST) including brain tumors (BT). Proc Am Soc Clin Oncol 9:296, 1990.

    Google Scholar 

  11. Pratt CB, Shanks E, Hustu HO, et al. Adjuvant multiple drug chemotherapy for osteosarcoma of the extremity. Cancer 39:51–57, 1977.

    Article  PubMed  CAS  Google Scholar 

  12. Pratt CB, Champion JE, Fleming ID, et al. Adjuvant chemotherapy for osteosarcoma of the extremity: long-term results of two consecutive prospective protocol studies. Cancer 65:439–445, 1990.

    Article  PubMed  CAS  Google Scholar 

  13. Pratt CB, Rivera G, Shanks E, et al. Combination chemotherapy for osteosarcoma. Cancer Treat Rep 62:251–257, 1978.

    PubMed  CAS  Google Scholar 

  14. Pratt CB. Outcome of patients failing adjuvant chemotherapy for osteosarcoma. Cancer Bull 34:100–103, 1982.

    Google Scholar 

  15. Link MP, Goorin AM, Miser AW, et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma. N Engl J Med 314:1600–1602, 1986.

    Article  PubMed  CAS  Google Scholar 

  16. Meyer WH, Pratt CB, Schell MJ, et al. The use of ifosfamide as initial therapy in osteosarcoma. In: Adjuvant Chemotherapy of Cancer, VI. Salmon SE, Ed. W.B. Saunders, Philadelphia, 1990, pp 580–585.

    Google Scholar 

  17. Meyer WH, Pratt CB, Rao B, et al. Preliminary results of a trial for previously untreated patients with osteosarcoma including ifosfamide as initial therapy. Proc Annu Meet Am Assoc Cancer Res 31:201, 1990.

    Google Scholar 

  18. Kumar APM, Green AA, Smith JW, Pratt CB. Combined therapy for malignant tumors of the chest wall in children. J Pediatr Surg 12:991–999, 1977.

    Article  PubMed  CAS  Google Scholar 

  19. Kumar APM, Pratt CB. Transmedullary amputation and resection of pulmonary metastases in osteosarcoma. J Pediatr Surg 12:427–435, 1977.

    Article  PubMed  CAS  Google Scholar 

  20. Meyer WH, Schell MJ, Kumar APM, et al. Thoracotomy for pulmonary metastatic osteosarcoma: an analysis of prognostic indicators of survival. Cancer 59:374–379, 1987.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, St. Jude Children’s Research Hospital, 332 North Lauderdale, P.O. Box 381, Memphis, TN, 38101-0318, USA

    C. B. Pratt & W. H. Meyer

  2. Department of Surgery, St. Jude Children’s Research Hospital, 332 North Lauderdale, P.O. Box 381, Memphis, TN, 38101-0318, USA

    B. N. Rao & I. D. Fleming

  3. Department of Pathology, St. Jude Children’s Research Hospital, 332 North Lauderdale, P.O. Box 381, Memphis, TN, 38101-0318, USA

    D. M. Parham

Authors
  1. C. B. Pratt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. H. Meyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. N. Rao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. M. Parham
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. I. D. Fleming
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medical College of Ohio at Toledo, USA

    G. Bennett Humphrey

  2. University of Groningen, Netherlands

    H. Schraffordt Koops , W. M. Molenaar  & A. Postma ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer Science+Business Media New York

About this chapter

Cite this chapter

Pratt, C.B., Meyer, W.H., Rao, B.N., Parham, D.M., Fleming, I.D. (1993). Osteosarcoma studies at St. Jude Children’s Research Hospital from 1968 through 1990. In: Humphrey, G.B., Koops, H.S., Molenaar, W.M., Postma, A. (eds) Osteosarcoma in Adolescents and Young Adults: New Developments and Controversies. Cancer Treatment and Research, vol 62. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3518-8_38

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-3518-8_38

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6561-7

  • Online ISBN: 978-1-4615-3518-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation